Cellebrite DI Ltd. (CLBT) NASDAQ
14.44
-0.09(-0.62%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.44
-0.09(-0.62%)
Currency In USD
| Market Cap | 4.56B |
| Enterprise Value | 4.45B |
| P/E Ratio | 49 |
| PEG Ratio | 15.19 |
| Price/Sales Ratio | 7.57 |
| Price/Book Ratio | 7.92 |
| Enterprise/Revenue | 7.36 |
| Enterprise/EBITDA | 41.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.16 |
| Operating Margin | 0.14 |
| Return On Assets | 0.08 |
| Return On Equity | 0.18 |
| Revenue | 475.68M |
| Revenue/Share | 1.79 |
| Gross Profit | 400.5M |
| EBITDA | 78.35M |
| Net Income | 78.33M |
| Diluted EPS | 0.31 |
| Total Cash | 437.05M |
| Total Cash/Share | 1.64 |
| Total Debt | 22.67M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 1.56 |
| Book Value Per Share | 1.82 |
| 52-Week Change | -20.88 |
| 52-Week High | 20.86 |
| 52-Week Low | 11.76 |
| Moving Average 50 Days | 15.42 |
| Moving Average 200 Days | 16.41 |
| Average Volume | 1.62M |
| Shares Outstanding | 249.44M |
| % Held by Institutions | 48.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |